Diabetes-related Amylin Dyshomeostasis: a Contributing Factor to Cerebrovascular Pathology and Dementia

키워드

참고문헌 (45)

1. Alzheimer's Association, "2019 Alzhiemer's disease facts and figures", Alzheimers Dement, 15, pp.321~387 (2019)
2. Iadecola C, "The pathobiology of vascular dementia", Neuron, 80, pp.844~866 (2013)
3. Tong X, "The burden of cerebrovascular disease in the United States", Prev Chronic Dis, 16, pp.E52~ (2019)
4. Rawlings AM, "Diabetes in midlife and cognitive change over 20 years: a cohort study", Ann Intern Med, 161, pp.785~793 (2014)
5. Okereke OI, "Type 2 diabetes mellitus and cognitive decline in two large cohorts of community-dwelling older adults", J Am Geriatr Soc, 56, pp.1028~1036 (2008)
6. Ott A, "Diabetes mellitus and the risk of dementia: The Rotterdam Study", Neurology, 53, pp.1937~1942 (1999)
7. Peila R, "Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study", Diabetes, 51, pp.1256~1262 (2002)
8. Geijselaers SL, "Glucose regulation, cognition, and brain MRI in type 2diabetes: a systematic review", Lancet Diabetes Endocrinol, 3, pp.75~89 (2015)
9. Crane PK, "Glucose levels and risk of dementia", N Engl J Med, 369, pp.1863~1864 (2013)
10. Cukierman-Yaffe T, "Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial", Diabetes Care, 32, pp.221~226 (2009)
11. Launer LJ, "Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy", Lancet Neurol, 10, pp.969~977 (2011)
12. Feinkohl I, "The impact of diabetes on cognitive decline: potential vascular, metabolic, and psychosocial risk factors", Alzheimers Res Ther, 7, pp.46~ (2015)
13. Westermark P, "Islet amyloid polypeptide, islet amyloid, and diabetes mellitus", Physiol Rev, 91, pp.795~826 (2011)
14. Ly H, "Brain microvascular injury and white matter disease provoked by diabetes-associated hyperamylinemia", Ann Neurol, 82, pp.208~222 (2017)
15. Jackson K, "Amylin deposition in the brain: a second amyloid in Alzheimer disease?", Ann Neurol, 74, pp.517~526 (2013)
16. Oskarsson ME, "In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease", Am J Pathol, 185, pp.834~846 (2015)
17. Banks WA, "Permeability of the blood-brain barrier to amylin", Life Sci, 57, pp.1993~2001 (1995)
18. Beaumont K, "High affinity amylin binding sites in rat brain", Mol Pharmacol, 44, pp.493~497 (1993)
19. Woods SC, "Pancreatic signals controlling food intake; insulin, glucagon and amylin", Philos Trans R Soc Lond B Biol Sci, 361, pp.1219~1235 (2006)
20. Westermark P, "Quantitative studies on amyloid in the islets of Langerhans", Ups J Med Sci, 77, pp.91~94 (1972)
21. Johnson KH, "Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus", N Engl J Med, 321, pp.513~518 (1989)
22. Clark A, "Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes", Diabetes Res, 9, pp.151~159 (1988)
23. Jurgens CA, "β-cell loss and β-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition", Am J Pathol, 178, pp.2632~2640 (2011)
24. Gong W, "Amylin deposition in the kidney of patients with diabetic nephropathy", Kidney Int, 72, pp.213~218 (2007)
25. Despa S, "Hyperamylinemia contributes to cardiac dysfunction in obesity and diabetes: a study in humans and rats", Circ Res, 110, pp.598~608 (2012)
26. Fawver JN, "Islet amyloid polypeptide (IAPP): a second amyloid in Alzheimer's disease", Curr Alzheimer Res, 11, pp.928~940 (2014)
27. Schultz N, "Amylin alters human brain pericyte viability and NG2expression", J Cereb Blood Flow Metab, 37, pp.1470~1482 (2017)
28. Verma N, "Intraneuronal amylin deposition, peroxidative membrane injury and increased IL-1β synthesis in brains of Alzheimer's disease patients with type-2diabetes and in diabetic HIP rats", J Alzheimers Dis, 53, pp.259~272 (2016)
29. Schultz N, "Levels of retinal IAPP are altered in Alzheimer's disease patients and correlate with vascular changes and hippocampal IAPP levels", Neurobiol Aging, 69, pp.94~101 (2018)
30. Moreno-Gonzalez I, "Molecular interaction between type 2 diabetes and Alzheimer's disease through cross-seeding of protein misfolding", Mol Psychiatry, 22, pp.1327~1334 (2017)
31. Biessels GJ, "Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications", Nat Rev Endocrinol, 14, pp.591~604 (2018)
32. Biessels GJ, "Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions", Lancet Diabetes Endocrinol, 2, pp.246~255 (2014)
33. Roostaei T, "Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer's disease", Mol Psychiatry, 22, pp.287~295 (2017)
34. Jhamandas JH, "Antagonist of the amylin receptor blocks β-amyloid toxicity in rat cholinergic basal forebrain neurons", J Neurosci, 24, pp.5579~5584 (2004)
35. Jhamandas JH, "Actions of β-amyloid protein on human neurons are expressed through the amylin receptor", Am J Pathol, 178, pp.140~149 (2011)
36. Lim YA, "Aβ and human amylin share a common toxicity pathway via mitochondrial dysfunction", Proteomics, 10, pp.1621~1633 (2010)
37. Srodulski S, "Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin", Mol Neurodegener, 9, pp.30~ (2014)
38. Guénet JL, "The mouse genome", Genome Res, 15, pp.1729~1740 (2005)
39. King AJ, "The use of animal models in diabetes research", Br J Pharmacol, 166, pp.877~894 (2012)
40. Neha, "Animal models of dementia and cognitive dysfunction", Life Sci, 109, pp.73~86 (2014)
41. Biessels GJ, "The impact of diabetes on cognition: what can be learned from rodent models?", Neurobiol Aging, 26(Suppl 1), pp.36~41 (2005)
42. Biessels GJ, "Risk of dementia in diabetes mellitus: a systematic review", Lancet Neurol, 5, pp.64~74 (2006)
43. Wang B, "Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes", Curr Diabetes Rev, 10, pp.131~145 (2014)
44. Farr SA, "Effects of leptin on memory processing", Peptides, 27, pp.1420~1425 (2006)
45. Matveyenko AV, "Islet amyloid polypeptide (IAPP) transgenic rodents as models for type 2diabetes", ILAR J, 47, pp.225~233 (2006)

관련 논문AI추천